Resultados CaixaResearch Health call 2023
Resultados CaixaResearch Health call 2023
CaixaResearch Health call 2023 information |
|
|---|---|
Total Budget |
25.334.874,34 € |
Number of proposals submitted |
493 |
Number of eligible proposals* |
430 |
Number of projects preselected |
85 |
Number of projects selected |
33 |
Success rate |
6,7 % |
* All the proposals submitted passed the format eligibility phase, thus the eligible proposals are those that also passed the content eligibility phase.
Table 1. General information of CaixaResearch Health Call 2023
Figure 1. Budget distribution by territory
Thematic Area |
Proposals submitted |
Eligible proposals |
Proj. Preselected (peer review) |
Proj. Selected (expert panel) |
|---|---|---|---|---|
Cardiovascular and metabolic diseases |
68 |
53 |
17 |
7 |
Neurosciences |
122 |
111 |
17 |
7 |
Infectious diseases |
69 |
59 |
17 |
8 |
Oncology |
110 |
96 |
17 |
6 |
Enabling technologies |
124 |
111 |
17 |
5 |
Table 2. Results by thematic area and evaluation phase
Thematic area |
Proposals submitted |
Eligible proposals |
Proj. Preselected |
Proj. Selected |
|
|---|---|---|---|---|---|
Cardiovascular and metabolic diseases |
Individual |
18 |
11 |
6 |
3 |
Research |
50 |
42 |
11 |
4 |
|
Neurosciences |
Individual |
45 |
38 |
5 |
1 |
Research |
77 |
73 |
12 |
6 |
|
Infectious diseases |
Individual |
33 |
28 |
8 |
7 |
Research |
36 |
31 |
9 |
1 |
|
Oncology |
Individual |
50 |
42 |
5 |
2 |
Research |
60 |
54 |
12 |
4 |
|
Enabling technologies |
Individual |
28 |
21 |
0 |
0 |
Research |
96 |
90 |
17 |
5 |
|
Table 3. Number of Individual and Research Consortium projects compared to the total number of projects of each thematic area
Project leader |
Proposals submitted |
Eligible proposals |
Proj. Preselected |
Proj. Selected |
Success rate |
|---|---|---|---|---|---|
Women |
196 |
176 |
31 |
13 |
6,6 % |
Men |
292 |
249 |
53 |
20 |
6,8 % |
Others / Prefer not to say |
5 |
5 |
1 |
0 |
0,0 % |
Table 4. Results by gender
Resultados CaixaResearch Health call 2022
Resultados CaixaResearch Health call 2022
CaixaResearch Health call 2022 information |
|
|---|---|
Total Budget |
23.148.611,88 € |
Number of projects presented |
547 |
Number of projects evaluated |
546 |
Number of projects preselected |
80 |
Number of projects selected |
33 |
Success rate |
6,04 % |
Table 1: General information of CaixaResearch Health Call 2022.
Figure 1: Budget distribution by territory
Thematic Area |
Proj. Evaluated |
Proj. Preselected (peer review) |
Proj. Selected (expert panel) |
||
|---|---|---|---|---|---|
Cardiovascular and metabolic diseases |
63 |
16 |
25,4 % |
5 |
7,9 % |
Neuroscience |
163 |
16 |
9,8 % |
8 |
4,9 % |
Infectious diseases |
72 |
16 |
22,2 % |
8 |
11,1 % |
Oncology |
111 |
16 |
14,4 % |
6 |
5,4 % |
Enabling technologies |
137 |
16 |
11,7 % |
6 |
4,4 % |
546 |
80 |
14,7 % |
33 |
6,0 % |
|
Table 2: % of the preselected and selected projects compared to the submitted projects in each thematic area.
Thematic area |
Proj. Evaluated |
Proj. Preselected |
Proj. Selected |
|
|---|---|---|---|---|
Cardiovascular and metabolic diseases |
Individual |
22 |
5 |
1 |
Research Consortium |
41 |
11 |
4 |
|
Total |
63 |
16 |
5 |
|
Neuroscience |
Individual |
70 |
5 |
4 |
Research Consortium |
93 |
11 |
4 |
|
Total |
163 |
16 |
8 |
|
Infectious disease |
Individual |
33 |
7 |
7 |
Research Consortium |
39 |
9 |
1 |
|
Total |
72 |
16 |
8 |
|
Oncology |
Individual |
52 |
5 |
3 |
Research Consortium |
59 |
11 |
3 |
|
Total |
111 |
16 |
6 |
|
Enabling technologies |
Individual |
34 |
1 |
1 |
Research Consortium |
103 |
15 |
5 |
|
Total |
137 |
16 |
6 |
|
|
|
549 |
80 |
33 |
Table 3: Number of Individual and Research Consortium projects compared to the total number of projects of each thematic area.
Resultados CaixaResearch Health call 2021
Resultados CaixaResearch Health call 2021
CaixaResearch Health call 2021 information |
|
|---|---|
HR21 Budget |
22.115.490,50 € |
Number of projects presented |
644 |
Number of projects evaluated |
644 |
Number of projects preselected |
70 |
Number of projects selected |
30 |
Success rate |
4,66 % |
Table: General information of Health Research 2021 Call for Proposals.
Resultados CaixaResearch Health call 2020
Resultados CaixaResearch Health call 2020
CaixaResearch Health call 2020 information |
|
|---|---|
HR20 Budget |
15.200.128 € |
Number of projects presented |
602 |
Number of projects evaluated |
600 |
Number of projects preselected |
62 |
Number of projects selected |
21 |
Success rate |
3,50 % |
Table: General information of Health Research 2020 Call for Proposals.
Resultados CaixaResearch Health call 2019
Resultados CaixaResearch Health call 2019
CaixaResearch Health call 2019 information |
|
|---|---|
HR18 Budget |
15.376.337 € |
Number of projects presented |
632 |
Number of projects evaluated |
629 |
Number of projects preselected |
75 |
Number of projects selected |
22 |
Success rate |
3,50 % |
Table: General information of Health Research 2019 Call for Proposals.
Resultados CaixaResearch Health call 2018
Resultados CaixaResearch Health call 2018
CaixaResearch Health call 2018 information |
|
|---|---|
HR17 Budget |
12.000.000 € |
Number of projects presented |
785 |
Number of projects evaluated |
785 |
Number of projects preselected |
77 |
Number of projects selected |
20 |
Table: General information of Health Research 2018 Call for Proposals.
Projetos selecionados CaixaResearch Health call 2023
Projetos selecionados CaixaResearch Health call 2023
Code |
Project Title |
Project Leader |
Host Organization |
Partner Organizations |
Thematic Area |
Category |
Budget (€) |
|---|---|---|---|---|---|---|---|
HR23-00050 |
Characterization of bacterial lipid rafts; inhibition of antibiotic resistance using anti-raft drugs |
Daniel Lopez Serrano |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Infectious disease |
HR Single Organization |
494,300.00 |
HR23-0051 |
Establishment of a precision medicine pipeline to personalize the treatment of brain metastasis |
Manuel Valiente |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III |
N/A |
Oncology |
HR Single Organization |
499,988.60 |
HR23-0060 |
Deciphering relapse in B-cell acute lymphoblastic leukemia |
Biola Javierre |
Fundació Institut de Recerca Contra la Leucèmia Josep Carreras |
Barcelona Supercomputing Center - Centro Nacional de Supercomputación (BSC-CNS); Fundació Josep Carreras contra la Leucemia |
Oncology |
HR Consortium |
999,999.92 |
HR23-0090 |
Applying DNA and optical barcoding to study endothelial progenitor cells in physiology and disease |
Mariona Graupera |
Fundació Institut de Recerca Contra la Leucèmia Josep Carreras |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC; Fundació Institut de Recerca Biomèdica (IRB Barcelona) |
Cardiovascular and associated metabolic diseases |
HR Consortium |
999,918.00 |
HR23-0124 |
The role of defects in mitochondria-associated ER membranes (MAM) to Amyotrophic Lateral Sclerosis |
Estela Area Gomez |
Consejo Superior de Investigaciones Científicas (CSIC) |
Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla; Institut De Recerca Biomedica De Lleida. Fundació Dr. Pifarre |
Neuroscience |
HR Consortium |
803,000.00 |
HR23-0173 |
Registry-based randomized trial to determine the role of Oxygen in acute Pulmonary Embolism |
David Jiménez |
Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal |
N/A |
Cardiovascular and associated metabolic diseases |
HR Single Organization |
499,999.00 |
HR23-0221 |
ChaoTROPIC Antimicrobial Hybrids for Bacterial Penetration |
Javier Montenegro |
Universidad de Santiago de Compostela |
Universidade Nova de Lisboa |
Infectious disease |
HR Consortium |
984,050.00 |
HR23-0361 |
ROLE OF RANK IN MYELOID CELLS AND TUMOR DEVELOPMENT |
Eva González Suárez |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III |
N/A |
Oncology |
HR Single Organization |
499,993.63 |
HR23-0367 |
Lab-grown red cells for the transfusion management of vaso-occlusive crisis in sickle cell patients |
Núria Nogués Gálvez |
Banc de Sang i Teixits |
University of Bristol |
Enabling Technologies |
HR Consortium |
941,350.12 |
HR23-0373 |
Systems analyses to stop mosquito-borne virus transmission: from mechanisms to biological control |
Juana Díez Antón |
Universitat Pompeu Fabra (UPF) |
N/A |
Infectious disease |
HR Single Organization |
430,400.00 |
HR23-0380 |
The molecular regulation of T cell development in the thymus: Implications for infectious diseases |
Nuno L. ALves |
Instituto de Investigação e Inovação em Saúde (i3S) |
N/A |
Infectious disease |
HR Single Organization |
499,005.00 |
HR23-0383 |
Targeting Imidazole Propionate in atherosclerosis |
David Sancho |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC |
Fundación KERTOR |
Cardiovascular and associated metabolic diseases |
HR Consortium |
967,620.20 |
HR23-0392 |
Single cell mapping of tumor-immune coevolution in organ-specific breast cancer metastasis |
Toni Celià-Terrassa |
Hospital del Mar Resarch Institute |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III; Leiden University Medical Centre |
Oncology |
HR Consortium |
999,868.30 |
HR23-0421 |
Multisite Smartphone-based Ecological Momentary Intervention for suicide prevention |
Enrique Baca Garcia |
Fundación Instituto de Investigación Sanitaria of the Fundación Jiménez Díaz |
Universidad de Oviedo; Universidad Carlos III de Madrid; Instituto de Biomedicina de Sevilla - Hospital Universitario Virgen del Rocío; DSAS: DESPRÉS DEL SUÏCIDI - ASSOCIACIÓ DE SUPERVIVENTS; Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) |
Neuroscience |
HR Consortium |
999,955.00 |
HR23-0442 |
The cell of origin of Pancreatic Cancer: novel opportunities for the early diagnosis and treatment |
Elisa Espinet Hernández |
Universitat de Barcelona |
Fundación Instituto de Investigacion Sanitaria de Aragon; NOVA.ID.FCT - Associação Para a Inovação e Desenvolvimento da FCT; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL); ASOCIACIÓN CÁNCER DE PÁNCREAS |
Oncology |
HR Consortium |
999,999.18 |
HR23-0484 |
Wireless Neural Guidance Device for Spinal Cord Injury Repair |
Nuno Silva |
Universidade do Minho |
LABORATORIO IBERICO INTERNACIONAL DE NANOTECNOLOGIA |
Enabling Technologies |
HR Consortium |
993,872.59 |
HR23-0499 |
Genetic variability in Plasmodium Liver Stage Schizogony |
Maria Mota |
Instituto de Medicina Molecular João Lobo Antunes |
N/A |
Infectious disease |
HR Single Organization |
499,999.50 |
HR23-0516 |
From metabolic space to neuronal space: mapping how nutrients affect brain function and behavior |
Carlos Ribeiro |
Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud |
European Molecular Biology Laboratory |
Neuroscience |
HR Consortium |
997,381.40 |
HR23-0558 |
Monkeypox virus cytokine decoy receptors: adaptation to human immune evasion and transmission |
Antonio Alcamí |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Infectious disease |
HR Single Organization |
499,800.00 |
HR23-0560 |
Lipid droplets as key players in brain microgliosis after stroke |
Anna M. Planas |
Consejo Superior de Investigaciones Científicas (CSIC) |
Tel Aviv University; Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer; Fundacio Ictus |
Neuroscience |
HR Consortium |
996,675.00 |
HR23-0608 |
Deciphering the impact of Leukaemia on Immunological Fitness beyond disease |
Nuno Rodrigues dos Santos |
Instituto de Investigação e Inovação em Saúde (i3S) |
Consejo Superior de Investigaciones Científicas (CSIC); University of Oxford |
Oncology |
HR Consortium |
981,307.27 |
HR23-0611 |
Novel genetic and mechanistic studies of hypertrophic cardiomyopathy |
José Luis de la Pompa |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC |
Universidad de Murcia; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Cardiovascular and associated metabolic diseases |
HR Consortium |
999,668.18 |
HR23-0679 |
Compact Analytical Tool for robust MALaria decentralized diagnosis and community surveillance |
Eva Baldrich Rubio |
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) |
Institut de Bioenginyeria de Catalunya; Consejo Superior de Investigaciones Científicas (CSIC) |
Enabling Technologies |
HR Consortium |
989,940.75 |
HR23-0682 |
Blocking bacterial glycosyltransferases to circumvent antibiotic resistance |
Didier Cabanes |
Instituto de Investigação e Inovação em Saúde (i3S) |
N/A |
Infectious disease |
HR Single Organization |
499,950.00 |
HR23-0683 |
Initiation of immune responses by surveillance of homeostasis perturbations |
Luís Ferreira Moita |
Fundação Calouste Gulbenkian |
N/A |
Infectious disease |
HR Single Organization |
499,900.00 |
HR23-0718 |
DOSImetry monitor for FLASH therapy |
Consuelo Guardiola |
Consejo Superior de Investigaciones Científicas (CSIC) |
Universidad de Santiago de Compostela; Institut Curie; Universidad de Sevilla |
Enabling Technologies |
HR Consortium |
971,936.00 |
HR23-0749 |
Personalizing diagnosis and treatment for Familial Hypercholesterolaemia patients |
Mafalda Bourbon |
Instituto Nacional de Saúde Doutor Ricardo Jorge |
University of Helsinki; Institut National de la Santé et de la Recherche Médicale - INSERM; Erasmus Medical Center; FH Europe |
Cardiovascular and associated metabolic diseases |
HR Consortium |
999,912.00 |
HR23-0793 |
Cannabis and psychoses: decoding the link |
Juan Pedro Bolaños |
Universidad de Salamanca |
Institut National de la Santé et de la Recherche Médicale - INSERM; Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) |
Neuroscience |
HR Consortium |
994,100.00 |
HR23-0799 |
Weber's Law: A mechanistic window into sensory dysfunction in autism spectrum disorders |
Alfonso Renart |
Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud |
N/A |
Neuroscience |
HR Single Organization |
499,998.40 |
HR23-0837 |
Advanced MIcroscopy for the study of Dynamic innate immunity activation by immunoGENIC cell death |
Francisco Sánchez Madrid |
Universidad Autónoma de Madrid |
Fundación para la Investigación Biomédica del Hospital de la Princesa; Consejo Superior de Investigaciones Científicas (CSIC) |
Enabling Technologies |
HR Consortium |
696,852.50 |
HR23-0840 |
Inflammation in Cardiovascular diseases: Mitochondrial Fgr Kinase as a therapeutic target |
José Antonio Enríquez Domínguez |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC |
N/A |
Cardiovascular and associated metabolic diseases |
HR Single Organization |
498,000.00 |
HR23-0860 |
Unravelling pro-regenerative signaling modules in the injured brain |
Christa Rhiner |
Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud |
Achucarro Basque Center for Neuroscience Fundazioa |
Neuroscience |
HR Consortium |
899,298.20 |
HR23-0881 |
Immune regulation of skeletal muscle metabolic health and exercise response in aging |
Pedro Sousa-Victor |
Instituto de Medicina Molecular João Lobo Antunes |
N/A |
Cardiovascular and associated metabolic diseases |
HR Single Organization |
499,835.60 |
Projetos selecionados CaixaResearch Health call 2022
Projetos selecionados CaixaResearch Health call 2022
Code |
Project Title |
Project Leader |
Host Organization |
Partner Organizations |
Thematic Area |
Category |
Budget (€) |
|---|---|---|---|---|---|---|---|
HR22-00073 |
Andrés Aguilera |
Universidad de Sevilla |
N/A |
Oncology |
Individual |
500,000 |
|
HR22-00100 |
João Morais Cabral |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação |
N/A |
Infectious disease |
Individual |
498,999 |
|
HR22-00123 |
Jordi Figuerola |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Infectious disease |
Individual |
499,909.28 |
|
HR22-00172 |
Elías Campo |
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
Fundación Universidad de Oviedo; Centre de Regulació Genòmica (CRG) |
Oncology |
Research Consortium |
999,806.30 |
|
HR22-00189 |
Paulo Aguiar |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação |
Universidade do Porto; Consejo Superior de Investigaciones Científicas (CSIC); Centro Hospitalar Universitário do Porto, E.P.E. |
Enabling Technologies |
Research Consortium |
965,888.78 |
|
HR22-00221 |
Josep Dalmau |
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
Fundació Privada per a la Recerca i la Docència Sant Joan de Déu |
Neuroscience |
Research Consortium |
972,352.39 |
|
HR22-00253 |
Almudena R. Ramiro |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC |
Fundación Instituto de Investigación Sanitaria of the Fundación Jiménez Díaz |
Cardiovascular and associated metabolic diseases |
Research Consortium |
750,042.40 |
|
HR22-00316 |
Understanding and promoting the growth and regenerative functions of blood vessels in heart disease |
Rui Benedito |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC |
Centre de Regulació Genòmica (CRG); Fundació Institut de Recerca Contra la Leucèmia Josep Carreras; University Hospital RWTH Aachen |
Cardiovascular and associated metabolic diseases |
Research Consortium |
999,948.04 |
HR22-00394 |
Angel Barco |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Neuroscience |
Individual |
498,000 |
|
HR22-00395 |
Vascularized lymphoma on-chip: a multifaceted tool for translational research |
Patricia Perez |
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
European Molecular Biology Laboratory Barcelona |
Enabling Technologies |
Research Consortium |
499,871.26 |
HR22-00402 |
Fran Supek |
Fundació Institut de Recerca Biomèdica (IRB Barcelona) |
Universitat Pompeu Fabra (UPF) |
Oncology |
Research Consortium |
998,900.50 |
|
HR22-00405 |
Accelerated evolution of high-weight protein complexes for precision antimicrobials |
Alfonso Jaramillo |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Enabling Technologies |
Individual |
482,730 |
HR22-00447 |
Metabolic communication between immune cells orchestrates the response to pathogens |
Nuria Martínez |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Infectious disease |
Individual |
496,685.86 |
HR22-00529 |
Novel mutational mechanisms of somatic retrotransposition in the context of the 3D cancer genome |
Jose Tubio |
Universidad de Santiago de Compostela |
N/A |
Oncology |
Individual |
495,476.89 |
HR22-00533 |
A DIRect QuanTitative assessment of Heart disease with magnetic resonance imaging |
Teresa Matias |
Centro De Ciências Do Mar Do Algarve |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC; Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento; Universidad de Valladolid |
Cardiovascular and associated metabolic diseases |
Research Consortium |
998,472.90 |
HR22-00551 |
Claudio Franco |
Instituto de Medicina Molecular |
N/A |
Cardiovascular and associated metabolic diseases |
Individual |
499,818.88 |
|
HR22-00569 |
NRF2 as a novel therapeutic target in early and intermediate age-related macular degeneration |
Miguel Seabra |
Universidade Nova de Lisboa |
Centro Investigation Biomedica en Redes Neurodegenerativas - CIBERNED |
Neuroscience |
Research Consortium |
985,013 |
HR22-00602 |
Marta Martínez |
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) |
Universitat Autònoma de Barcelona (UAB); Centro de Investigación Príncipe Felipe |
Neuroscience |
Research Consortium |
599,723.00 |
|
HR22-00668 |
Uncovering the Differentiation Determinants and Dynamics of Congenital Susceptibility to Infections |
Esteban Ballestar |
Fundació Institut de Recerca Contra la Leucèmia Josep Carreras |
Fundació Josep Carreras contra la Leucemia |
Infectious disease |
Individual |
477,722.19 |
HR22-00681 |
Christian Brander |
Institut de Recerca de la Sida "la Caixa" - IRSICAIXA |
Centre de Regulació Genòmica (CRG); Fundació FLS de lluita contra la sida, les malalties infeccioses i la promoció de la salut i la ciencia; Institut De Recerca I Tecnología Agroalimentaria |
Infectious disease |
Research Consortium |
999,580 |
|
HR22-00702 |
Multifunctional nano-immunotherapy against breast brain metastases |
Helena Florindo |
FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento |
Tel Aviv University |
Enabling Technologies |
Research Consortium |
853,405.70 |
HR22-00722 |
The BioPlaTTAR Platform for the Tailored and Rapid Development of Antiviral Biopharmaceuticals |
Cláudio Manuel Soares |
Universidade Nova de Lisboa |
Instituto de Medicina Molecular; Fundação Calouste Gulbenkian; Consejo Superior de Investigaciones Científicas (CSIC) |
Enabling Technologies |
Research Consortium |
1,000,000 |
HR22-00732 |
Somatic mutations and clonal hematopoiesis as predictors and drivers of heart failure progression |
José Javier Fuster |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC |
Fundació Institut de Recerca Contra la Leucèmia Josep Carreras; Fundació Institut d’Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP); Fundació Josep Carreras contra la Leucemia; Fundació Institut de Recerca Biomèdica (IRB Barcelona); Fundación para la Formación e Investigación Sanitarias de la Región de Murcia |
Cardiovascular and associated metabolic diseases |
Research Consortium |
998,043.28 |
HR22-00741 |
Luis Graca |
Instituto de Medicina Molecular |
Cultivamos Cultura |
Infectious disease |
Individual |
499,952 |
|
HR22-00754 |
Manuela Ferreira |
Universidade de Coimbra |
N/A |
Infectious disease |
Individual |
408,077.71 |
|
HR22-00776 |
Role of cellular senescence during breast cancer progression and treatment |
Joaquín Arribas |
Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) |
N/A |
Oncology |
Individual |
500,000 |
HR22-00778 |
Leopoldo Petreanu |
Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud |
N/A |
Neuroscience |
Individual |
499,976.40 |
|
HR22-00799 |
Vera Sofia Correia Martins |
Fundação Calouste Gulbenkian |
Universität Ulm |
Oncology |
Research Consortium |
681,932.54 |
|
HR22-00813 |
Miguel A. Bañares |
Consejo Superior de Investigaciones Científicas (CSIC) |
Fundación para la Investigación Biomédica del Hospital Universitario La Paz; Hospital Universitario Severo Ochoa |
Enabling Technologies |
Research Consortium |
997,000 |
|
HR22-00854 |
Ira Milosevic |
Universidade de Coimbra |
N/A |
Neuroscience |
Individual |
492,837.85 |
|
HR22-00879 |
Cristina Cunha |
Universidade do Minho |
N/A |
Infectious disease |
Individual |
499,646.79 |
|
HR22-00890 |
Modulating nucleolar activity and stress responses as a therapeutic strategy in ALS |
Oscar Fernandez-Capetillo |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III |
N/A |
Neuroscience |
Individual |
498,850 |
Projetos selecionados CaixaResearch Health call 2021
Projetos selecionados CaixaResearch Health call 2021
Code |
Project Title |
Project Leader |
Host Organization |
Partner Organizations |
Thematic Area |
Category |
Budget (€) |
|---|---|---|---|---|---|---|---|
HR21-00046 |
Decoding the paracrine control of metabolic fitness by endothelial nutrient signaling |
Alejo Efeyan |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
Cardiovascular and associated metabolic diseases |
Research Consortium |
992.580,60 |
HR21-00386 |
Amadeu Llebaria |
Consejo Superior de Investigaciones Científicas (CSIC) |
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) - Purdue University, West Lafayette, IN - GICOR |
Cardiovascular and associated metabolic diseases |
Research Consortium |
999.779,50 |
|
HR21-00430 |
Antonio Zorzano |
Fundació Institut de Recerca Biomèdica (IRB Barcelona) |
Universitat de Barcelona - Fundació Institut d'Investigació Sanitària Pere Virgili |
Cardiovascular and associated metabolic diseases |
Research Consortium |
997.014 |
|
HR21-00233 |
Silvia Giuliana Priori |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC |
N/A |
Cardiovascular and associated metabolic diseases |
Individual |
496.100 |
|
HR21-00793 |
Cecilia Rodrigues |
FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento |
N/A |
Cardiovascular and associated metabolic diseases |
Individual |
320.000,07 |
|
HR21-00375 |
Ben Lehner |
Centre de Regulació Genòmica (CRG) |
Institut de Bioenginyeria de Catalunya |
Enabling technologies |
Research Consortium |
994.048,90 |
|
HR21-00925 |
Development of enabling technologies for T-cell immunotherapy of solid tumors |
Sonia Guedán |
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
Asociación Centro de Investigación Cooperativa en Biociencias (CIC bioGUNE) - Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO) |
Enabling technologies |
Research Consortium |
963.488 |
HR21-00410 |
Pedro Alpuim |
Laboratorio Iberico Internacional de Nanotecnologia |
Universidade do Minho - Consejo Superior de Investigaciones Científicas (CSIC) |
Enabling technologies |
Research Consortium |
997.692,19 |
|
HR21-00208 |
Enzyme propelled nanobots as efficient nanotech platform for bladder cancer therapy |
Samuel Sánchez |
Institut de Bioenginyeria de Catalunya |
Asociación Centro de Investigación Cooperativa en Biomateriales - Universitat Autònoma de Barcelona (UAB) - Fundació Clínic per a la Recerca Biomèdica -Fundacio Catalunya-La Pedrera Fundacio Especial - Universitat de Barcelona - Fundació Bosch i Gimpera |
Enabling Technologies |
Research Consortium |
997.946,50 |
HR21-00415 |
Margarida Saraiva |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação |
Consejo Superior de Investigaciones Científicas (CSIC) - Francis Crick Institute |
Infectious diseases |
Research Consortium |
998.404 |
|
HR21-00848 |
Whole-organism vaccines against P. falciparum and P. vivax malaria with enhanced efficacy and scope |
Miguel Prudêncio |
Instituto de Medicina Molecular |
Leiden University Medical Centre - US Naval Medical Research Unit 6 |
Infectious diseases |
Research Consortium |
997.453,50 |
HR21-01020 |
João Filipe Oliveira |
Universidade do Minho |
N/A |
Neuroscience |
Individual |
499.478,45 |
|
HR21-00171 |
Hernando A. del Portillo |
Institut de Salut Global de Barcelona (ISGlobal) |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação - Universitat de Barcelona - Mahidol University |
Infectious diseases |
Research Consortium |
996.930,57 |
|
HR21-00368 |
Molecular dissection of TNF-mediated pathogenic macrophage necrosis in tuberculosis |
Francisco Jose Roca Soler |
Universidad de Murcia |
N/A |
Infectious diseases |
Individual |
460.252,80 |
HR21-00737 |
Toni Gabaldón |
Fundació Institut de Recerca Biomèdica (IRB Barcelona) |
N/A |
Infectious diseases |
Individual |
499.244 |
|
HR21-00622 |
In vivo reprogramming to rescue alterations in Huntington’s disease |
Josep M. Canals |
Universitat de Barcelona - Fundació Bosch i Gimpera |
Lund University - Cardiff University - Institute of Molecular Biotechnology (IMBA)- European Huntington's Disease Network |
Neuroscience |
Research Consortium |
994.890 |
HR21-00259 |
From GFAP mutations in astrocytes to neurodegeneration: exploring a lipid-protein oxidation pathway |
Dolores Pérez-Sala |
Consejo Superior de Investigaciones Científicas (CSIC) |
Brain Center, University Medical Center Utrecht -University of Copenhagen - University of Gothenburg -Institut De Recerca Biomedica De Lleida. Fundació Dr. Pifarre |
Neuroscience |
Research Consortium |
1.000.000 |
HR21-00824 |
A strategy to guide and promote spinal and visual axons regeneration after injury |
Eloísa Herrera |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Neuroscience |
Individual |
495.500 |
HR21-01136 |
Deep learning of a hippocampal memory code in health and disease |
Liset Menéndez de la Prida |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Neuroscience |
Individual |
491.700 |
HR21-01208 |
RBM10, a novel splicing regulator and tumor suppressor: from mechanisms to therapies |
Juan Valcárcel |
Centre de Regulació Genòmica (CRG) |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III |
Oncology |
Research Consortium |
816.239,46 |
HR21-00176 |
Maite Huarte |
Fundación para la Investigación Médica Aplicada (FIMA/CIMA) |
Consejo Superior de Investigaciones Científicas (CSIC) - Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III |
Oncology |
Research Consortium |
995.200 |
|
HR21-00761 |
IL7R in lung cancer development, metastasis and resistance to immune checkpoint inhibitor therapy |
João Barata |
Instituto de Medicina Molecular |
Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre - Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III |
Oncology |
HR Consortium |
999.962 |
HR21-00083 |
Interleukin-8 and neutrophil extracelular traps as actionable hurdles for cancer immunotherapy |
Ignacio Melero |
Fundación para la Investigación Médica Aplicada (FIMA/CIMA) |
N/A |
Oncology |
Individual |
498.850 |
HR21-00020 |
Helder Maiato |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação |
N/A |
Oncology |
Individual |
499.983 |
|
| Projetos premiados em colaboração com a Fundação Luzon | |||||||
HR21-00931 |
Targeting TDP-43 with protein kinase inhibitors: a effective and measurable therapy for ALS |
Ana Martinez |
Consejo Superior de Investigaciones Científicas (CSIC) |
FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento -Universidad Complutense de Madrid |
Neuroscience |
Research Consortium |
500.000 |
| Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b" | |||||||
HR21-01212 |
Jose Bessa |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação |
N/A |
Cardiovascular and associated metabolic diseases |
Individual |
499.355 |
|
HR21-00605 |
Miguel Castanho |
Instituto de Medicina Molecular |
Asociación Instituto Biodonostia - FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento - Asociación Centro de Investigación Cooperativa en Biomateriales |
Enabling Technologies |
Research Consortium |
632.841 |
|
HR21-00533 |
A flexible platform for generating synthetic virus to control infectious diseases |
Joana Azeredo |
Universidade do Minho |
N/A |
Infectious diseases |
Individual |
492.460,48 |
HR21-01077 |
Paulo Pinheiro |
Centro de Neurociências e Biologia Celular |
N/A |
Neuroscience |
Individual |
492.304,48 |
|
HR21-00077 |
Claus Maria Azzalin |
Instituto de Medicina Molecular |
N/A |
Oncology |
Individual |
495.792 |
|
Projetos selecionados CaixaResearch Health call 2020
Projetos selecionados CaixaResearch Health call 2020
Code |
Project Title |
Project Leader |
Host Institution |
Partner Institutions |
Thematic Area |
Category |
Budget (€) |
|---|---|---|---|---|---|---|---|
HR20-00493 |
Manuel Irimia |
Centre de Regulació Genòmica (CRG) |
N/A |
Cardiovascular and metabolic diseases |
Individual |
499.592 |
|
HR20-00075 |
Miguel Ángel del Pozo |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC |
Yale University, New Haven, CT, Aarhus University, Asociación Centro de Investigación Cooperativa en Biomateriales |
Cardiovascular and metabolic diseases |
Research Consortium |
999.987 |
|
HR20-00322 |
RNA mis-splicing in hypertrophic cardiomyopathy: opportunities for diagnosis and therapy |
Maria Carmo-Fonseca |
Instituto de Medicina Molecular |
Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento, Associação para Investigação e Desenvolvimento da Faculdade de Medicina |
Cardiovascular and metabolic diseases |
Research Consortium |
986.964 |
HR20-00051 |
Succinate/SUCNR1 axis: a novel target for anti-obesity therapies |
Sonia Fernandez |
Fundació Institut d'Investigació Sanitària Pere Virgili |
Universidad de Santiago de Compostela, Institut D'Investigació Biomèdica De Girona (IDIBGI) |
Cardiovascular and metabolic diseases |
Research Consortium |
998.902 |
HR20-00369 |
Enabling technologies to map nuclear mechanosensing: from organoids to tumors |
Xavier Trepat |
Institut de Bioenginyeria de Catalunya |
Netherlands Cancer Institute |
Enabling technologies |
Research Consortium |
984.630 |
HR20-00800 |
Deep Learning to Dissect the Interaction between Leukemic Cells and the Ageing Niche |
M. Carolina Florian |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Universität Ulm |
Enabling technologies |
Research Consortium |
817.045 |
HR20-00637 |
BioPrinted hydROgel MicrofluIdicS to mimic patient-specific tumor mEtastatic microenvironment |
Elena Martinez |
Institut de Bioenginyeria de Catalunya |
Laboratorio Ibérico Internacional de Nanotecnologia, Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO) |
Enabling technologies |
Research Consortium |
981.675 |
HR20-00428 |
Gemma Triola |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Enabling technologies |
Individual |
341.242 |
|
HR20-00218 |
Enhancing Tissue-Specific Immune Microenvironments for the Cure of HIV |
María José Buzón |
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) |
Consejo Superior de Investigaciones Científicas (CSIC), Institut de Recerca de la Sida "la Caixa" - IRSICAIXA |
Infectious diseases |
Research Consortium |
699.134 |
HR20-00361 |
Mechanism and function of epitranscriptomic poly(A) tail modifications in African trypanosomes |
Luisa Figueiredo |
Instituto de Medicina Molecular Joao Lobo Antunes |
N/A |
Infectious diseases |
Individual |
499.400 |
HR20-00635 |
Elena Gomez-Díaz |
Consejo Superior de Investigaciones Científicas (CSIC) |
University of Glasgow, University of Sciences, Techniques and Technologies of Bamako (USTTB), Malaria Rsearch and Training Center |
Infectious diseases |
Research Consortium |
999.548 |
|
HR20-00584 |
Olga Genilloud |
Fund. Centro de Excelencia en Inv. de Medicamentos Innovadores en Andalucia |
Drugs for Neglected Diseases Initiative (DNDi), Institut Pasteur korea |
Infectious diseases |
Research Consortium |
995.251 |
|
HR20-01000 |
Encoding reward and aversion in the mammalian brain: the overlooked role of endogenous opioids |
Ana Joao Rodrigues |
Universidade do Minho |
N/A |
Neuroscience |
Individual |
499.788 |
HR20-00083 |
Restoration of sensory circuits based on glia-to-neuron reprogramming |
Guillermina López-Bendito |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Neuroscience |
Individual |
499.000 |
HR20-00081 |
Amino acid transporter structure to target glutamate transmission in neuro diseases |
Manuel Palacin |
Fundació Institut de Recerca Biomèdica (IRB Barcelona) |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III |
Neuroscience |
Research Consortium |
428.500 |
HR20-00896 |
Mitochondrial transcription as a trigger for neurodegenation |
Albert Quintana |
Universitat Autònoma de Barcelona (UAB) |
N/A |
Neuroscience |
Individual |
500.000 |
HR20-00714 |
Guglielmo Foffani |
Fundación de Investigación HM Hospitales |
N/A |
Neuroscience |
Individual |
500.000 |
|
HR20-00465 |
Immunomodulatory drivers in melanoma progression and therapy response |
Marisol Soengas |
Fund. del Sector Público Estatal Centro Nacional de Inv. Oncológicas Carlos III |
N/A |
Oncology |
Individual |
481.597 |
HR20-00164 |
Xose R. Bustelo |
Fundación de Investigación del Cancer |
N/A |
Oncology |
Individual |
498.300 |
|
HR20-00871 |
Felipe Prosper |
Universidad de Navarra |
Fundación para la Investigación Médica Aplicada (FIMA/CIMA), Fundación Miguel Servet - Navarrabiomed, University of Cambridge |
Oncology |
Research Consortium |
999.410 |
|
HR20-00411 |
Luciano Di Croce |
Centre de Regulació Genòmica (CRG) |
Fundació Sant Joan de Déu |
Oncology |
Research Consortium |
990.160 |
|
| Proyectos galardonados en colaboración con la Fundación Luzón | |||||||
HR20-01109 |
Brain Liquid Biopsy for Alzheimer disease and neurodegenerative disorders |
Maite Mendioroz |
Fundación Miguel Servet - Navarrabiomed |
N/A |
Neuroscience |
Individual |
482.847 |
| Proyectos galardonados en colaboración con la Fundação para a Ciência e a Tecnologia, I.P. en el marco de la “Iniciativa Ibérica de Investigaçao e Inovaçao Biomédica, i4b" | |||||||
HR20-00249 |
Jana B. Nieder |
Laboratorio Ibérico Internacional de Nanotecnologia |
Universidade do Minho, Universidade de Aveiro |
Enabling technologies |
Research Consortium |
999.981 |
|
HR20-00841 |
Henrique Veiga-Fernandes |
Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud |
N/A |
Infectious disease |
Individual |
499.950 |
|
HR20-00904 |
Potassium channel dysfunction in models of neurodevelopmental disorders |
Ana Luisa Carvalho |
Centro de Neurociências e Biologia Celular |
IINS - Interdisciplinary Institute for Neuroscience, CNRS 5297, University of Bordeaux |
Neuroscience |
Research Consortium |
782.000 |
Projetos selecionados CaixaResearch Health call 2019
Projetos selecionados CaixaResearch Health call 2019
Code |
Project Title |
Project Leader |
Host Institution |
Partner Institutions |
Thematic Area |
Category |
Budget (€) |
|---|---|---|---|---|---|---|---|
HR1818-00120 |
Mariona Graupera |
Institut d'Investigació Biomèdica de Bellvitge |
Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.), Fundación Privada Hospital de la Santa Creu i Sant Pau, Fundació Sant Joan de Déu |
Cardiovascular and metabolic diseases |
Research Consortium |
755.018 |
|
HR1818-00068 |
Juan Miguel Redondo Moya |
Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) |
Consejo Superior de Investigaciones Científicas |
Cardiovascular and metabolic diseases |
Research Consortium |
500.000 |
|
HR1818-00304 |
Dysfunction of Ion Channel Complexes in Inheritable Cardiac Diseases |
José Jalife |
Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) |
N/A |
Cardiovascular and metabolic diseases |
Individual |
499.895 |
HR1818-00100 |
Marc Claret Carles |
Institut d'Investigacions Biomèdiques August Pi i Sunyer |
Université catholique de Louvain (UCLouvain), Universidad de Santiago de Compostela |
Cardiovascular and metabolic diseases |
Research Consortium |
972.183 |
|
HR1818-00359 |
Origin and functions of the tumor stroma in metastatic colorectal cancer |
Eduard Batlle |
Fundació Institut de Recerca Biomèdica (IRB Barcelona) |
N/A |
Oncology |
Individual |
499.997 |
HR1818-00069 |
Next-generation CAR-DOT cells for allogeneic adoptive cancer immunotherapy |
Bruno Miguel de Carvalho Silva-Santos |
Instituto de Medicina Molecular |
Josep Carreras Leukemia Research Institute (JCLRI) |
Oncology |
Research Consortium |
999.997 |
HR1818-00302 |
Post-transcriptional gene regulation reprogramming in obesity-driven liver cancer |
Raúl Méndez |
Fundació Institut de Recerca Biomèdica (IRB Barcelona) |
N/A |
Oncology |
Individual |
499.883 |
HR1818-00256 |
Defining The Role of Exosome-Secreted Micropeptides in Pancreatic Cancer |
Maria Abad |
Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO) |
Fundación Centro Nacional de Investigaciones Oncológicas Carlos III, Champalimaud Foundation |
Oncology |
Research Consortium |
694.600 |
HR1818-00023 |
Maria A. Blasco |
Fundación Centro Nacional de Investigaciones Oncológicas Carlos III |
N/A |
Oncology |
Individual |
489.100 |
|
HR1818-00589 |
Sensitizing pancreatic cancer to immunotherapy with multimodal precision nanomedicines |
Maria Jesús Vicent Docón |
Centro de Investigación Príncipe Felipe |
Facultade de Farmacia da Universidade de Lisboa, Sackler Faculty of Medicine. Tel Aviv University |
Enabling technologies |
Research Consortium |
985.042 |
HR1818-00501 |
Pau Gorostiza Langa |
Institut de Bioenginyeria de Catalunya |
Universidad Miguel Hernández de Elche (UMH), Consejo Superior de Investigaciones Científicas, Barcelona Macula Foundation Research (BMF), Universidad de Alcalá (UAH) |
Enabling technologies |
Research Consortium |
498.051 |
|
HR1818-00336 |
Community-Driven Big Data Intelligence to Fight Mosquito-Borne Disease |
Frederic Bartumeus Ferré |
Consejo Superior de Investigaciones Científicas |
Universitat Pompeu Fabra, Max Planck Institute for Demographic Research (MPDIR), National Center of Epidemiology (CNE). CIBERESP/ISCIII., Centre for Ecological Research and Forestry Applications (CREAF), Agència de Salut Pública de Barcelona (ASPB),Agencia de Salut Pública de Catalunya (ASPCAT). Generalitat de Catalunya, Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES) |
Enabling technologies |
Research Consortium |
999.920 |
HR1818-00313 |
Jose Antonio Garrido Ariza |
Fundació Institut Català de Nanociència i Nanotecnologia |
Institut de Física d'Altes Energies (IFAE), The Institute of Photonic Sciences (ICFO), Barraquer Foundation (BF), Institut de la Vision (Sorbonne Université) |
Enabling technologies |
Research Consortium |
999.715 |
|
HR1818-00058 |
Bacterial lung chassis for treating human lung infectious diseases |
Luis Serrano Pubul |
Fundació Centre de Regulació Genòmica |
Institut d'Investigacions Biomèdiques August Pi i Sunyer |
Infectious diseases |
Research Consortium |
999.528 |
HR1818-00469 |
Carmen Gil |
Consejo Superior de Investigaciones Científicas |
Instituto de Investigación Biomédica Hospital 12 de Octubre (Imas12), Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Bernhard Nocht Institute for Tropical Medicine |
Infectious disease |
Research Consortium |
995.068 |
|
HR1818-00267 |
Alfred Cortés Closas |
Barcelona Institute for Global Health (ISGlobal) |
N/A |
Infectious diseases |
Individual |
499.400 |
|
HR1818-00104 |
Marc Veldhoen |
Instituto de Medicina Molecular |
N/A |
Infectious diseases |
Individual |
497.158 |
|
HR1818-00155 |
Exosome targeting of the hypothalamus: a novel strategy for the treatment of obesity |
Miguel Antonio López Pérez |
Universidad de Santiago de Compostela |
N/A |
Neuroscience |
Individual |
448.300 |
HR1818-00026 |
DUbbing Language-therapy CINEma-based in Aphasia post-Stroke. A feasibility cross-over pilot-trial |
Blanca Fuentes Gimeno |
Hospital Universitario la Paz |
Universidad Pontificia de Comillas, Afasia Activa |
Neuroscience |
Research Consortium |
308.066 |
HR1818-00178 |
Manuel Francisco Carreiras Valiña |
Asociacion Basque Center on Cognition, Brain and Language |
N/A |
Neuroscience |
Individual |
500.000 |
|
HR1818-00452 |
José Antonio Del Río Fernández |
Institut de Bioenginyeria de Catalunya |
Institut d'Investigació Biomèdica de Bellvitge, Institute for Research in Biomedicine (IRB Barcelona), Universitat de Barcelona and Institute of Complex Systems (UBICS) |
Neuroscience |
Research Consortium |
763.002 |
|
HR1818-00007 |
Oscar Vilarroya Oliver |
Universitat Autònoma de Barcelona |
Fundació Institut Mar d'Investigacions Mèdiques, Instituto de Investigación Sanitaria Gregorio Marañón , University of Lleida-IRBLleida, Reproductive Medicine Service at Dexeus Women Health |
Neuroscience |
Research Consortium |
972.414 |
|
| Projetos premiados em colaboração com a Fundação Luzon | |||||||
HR1818-000341 |
A potential metabolic-targeted therapeutic for Amyotrophic lateral sclerosis (ALS): Leptin |
Carmen Maria Fernandez-Martos |
Fundación Hospital Nacional de Parapléjicos |
San Pablo University, King´s College London and Wicking Dementia Centre/University of Tasmania |
Neuroscience |
Research Consortium |
499979 |
| Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b" | |||||||
HR1818-00187 |
Targeting induced-senescent cells: a novel approach to promote spinal cord regeneration in mammals |
Leonor Saúde |
Instituto de Medicina Molecular |
N/A |
Neuroscience |
Individual |
444048 |
HR1818-00502 |
Miguel Che Parreira Soares |
Fundação Calouste Gulbenkian |
Universitätsklinikum Jena, Center for Sepsis Control and Care, Thüringen (Germany) |
Infectious disease |
Research Consortium |
500000 |
|
Projetos selecionados CaixaResearch Health call 2018
Projetos selecionados CaixaResearch Health call 2018
Code |
Project Title |
Project Leader |
Host Institution |
Partner Institutions |
Thematic Area |
Category |
Budget (€) |
|---|---|---|---|---|---|---|---|
HR17- 00016 |
Francisco Sánchez-Madrid |
Centro Nacional de Investigaciones Cardiovasculares (CNIC) |
N/A |
Infectious disease |
A |
499.731 |
|
HR17- 00040 |
Pura Muñoz-Cánoves |
Universitat Pompeu Fabra (UPF) |
N/A |
Other biomedical areas |
A |
496.630 |
|
HR17- 00092 |
Roger Gomis Cabré |
Institute for Research in Biomedicine (IRB) |
N/A |
Oncology |
A |
489.400 |
|
HR17- 00094 |
Eradicating prostate cancer metastasis before clinical manifestation |
Arkaitz Carracedo |
CIC bioGUNE |
University of Cambridge (UK), Fundação Champalimaud (Lisboa), CIC biomaGUNE, Basurto Hospital |
Oncology |
A |
499.915 |
HR17- 00149 |
Josep Dalmau Obrador |
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
N/A |
Neuroscience |
A |
498.718 |
|
HR17- 00199 |
Towards a universal therapeutic vaccine against chronic virus infections |
Andreas Meyerhans |
Universitat Pompeu Fabra (UPF) |
IrsiCaixa |
Infectious disease |
A |
484.316 |
HR17- 00221 |
Elías Campo |
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
Universidad de Oviedo (UNIOVI), Barcelona Supercomputing Center (BSC) |
Oncology |
B |
999.270 |
|
HR17- 00231 |
Maria Pia Cosma |
Fundació Centre de Regulació Genòmica (CRG) |
Institute for Bioengineering of Catalonia (IBEC), Instituto Barraquer |
Neuroscience |
A |
499.519 |
|
HR17- 00232 |
Exploiting post-transcriptional regulation to uncover novel vulnerabilities of metastatic cells |
Fátima Gebauer Hernández |
Fundació Centre de Regulació Genòmica (CRG) |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Oncology |
A |
499.980 |
HR17- 00247 |
Almudena Rodríguez Ramiro |
Centro Nacional de Investigaciones Cardiovasculares (CNIC) |
Fundación Jimenez Diaz |
Cardiovascular disease |
A |
499.963 |
|
HR17- 00264 |
Plasmodium Exploitation of Liver-specific Methionine Metabolism |
Maria M. Mota |
Instituto de Medicina Molecular (IMM), Lisboa |
N/A |
Infectious disease |
A |
499.950 |
HR17- 00267 |
Somatic Mutation-driven Clonal Hematopoiesis in Atherosclerosis - International Consortium |
Valentí Fuster |
Centro Nacional de Investigaciones Cardiovasculares (CNIC) |
University of Virginia (UVA) |
Cardiovascular disease |
B |
999.896 |
HR17- 00268 |
Therapeutic targeting of MBNL microRNAs as innovative treatments for myotonic dystrophy |
Ruben Artero-Allepuz |
Universitat de Valencia |
University of Oxford (UK), Institute for Bioengineering of Catalonia (IBEC), Institut IMAGINE (France), Institute Biodonostia, ASEM & Myotonic Dystrophy Foundation |
Other biomedical areas |
B |
997.024 |
HR17- 00323 |
Optical dissection of cortical circuits for sensory expectations |
Leopoldo Petreanu |
Fundação Champalimaud, Lisboa |
N/A |
Neuroscience |
A |
499.708 |
HR17- 00409 |
David Andreu Martínez |
Universitat Pompeu Fabra (UPF) |
Instituto de Medicina Molecular (IMM), Instituto de Bioquímica Médica Leopoldo de Meis |
Infectious disease |
B |
777.250 |
|
HR17- 00513 |
Miquel Vila Bover |
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) |
N/A |
Neuroscience |
A |
466.004 |
|
HR17- 00527 |
Therapeutic targeting of the neutrophil clock in cardiovascular disease |
Andrés Hidalgo Alonso |
Centro Nacional de Investigaciones Cardiovasculares (CNIC) |
Universidad Complutense de Madrid (UCM), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
Cardiovascular disease |
A |
499.998 |
HR17- 00539 |
Carlos Vidal Ribeiro |
Fundação Champalimaud, Lisboa |
N/A |
Neuroscience |
A |
463.694 |
|
HR17- 00595 |
Colin Adrain |
Calouste Gulbenkian Foundation, Lisboa |
Institute of Chemical and Biological Technology (ITQB-NOVA, Lisboa), Institute of Organic Chemistry and Biochemistry of the CAS (Czech Republic) |
Other biomedical areas |
B |
960.769 |
|
HR17- 00627 |
Ofelia María Martínez Estrada |
Fundació Bosch i Gimpera (UB) |
Fundació Hospital Universitari Vall d'Hebron Institut de Recerca (VHIR), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP) |
Cardiovascular disease |
A |
438.100 |
|
| Projetos premiados em colaboração com a Fundação Luzon | |||||||
HR17- 00777 |
Rubèn López Vales |
Universitat Autònoma de Barcelona (UAB) |
N/A |
Neuroscience |
A |
500.000 |
|
| Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b" | |||||||
HR17- 00523 |
Rodrigo A. Cunha |
Centro de Neurociências e Biologia Celular (CNC), Coimbra |
N/A |
Neuroscience |
A |
333.516 |
|
HR17- 00634 |
Agostinho Albérico Rodrigues de Carvalho |
Universidade do Minho |
Fundación Universitaria San Pablo (CEU), Foundation for Research and Technology-Hellas, Jena University Hospital and Radboudumc |
Infectious disease |
B |
999.027 |
|
HR17- 00601 |
Exosomal fat-liver axis in nonalcoholic fatty liver disease: function and targeting |
Rui Eduardo Mota Castro |
Universidade de Lisboa |
Instituto Biodonostia, École polytechnique fédérale de Lausanne (EPFL) and CIC bioGUNE |
Other biomedical areas |
A |
500.000 |
HR17- 00636 |
Joaquim Adelino Correia Ferreira Leite Moreira |
Universidade do Porto |
N/A |
Cardiovascular disease |
A |
369.248 |
|
Resultados Health Research 2022
Resultados Health Research 2022
Caixaresearch Health 2022 information |
|
|---|---|
Total Budget |
23.148.611,88 € |
Number of projects presented |
547 |
Number of projects evaluated |
546 |
Number of projects preselected |
80 |
Number of projects selected |
33 |
Success rate |
6,04 % |
Table 1: General information of CaixaResearch Health Call 2022.
Figure 1: Budget distribution by territory
Thematic Area |
Proj. Evaluated |
Proj. Preselected (peer review) |
Proj. Selected (expert panel) |
||
|---|---|---|---|---|---|
Cardiovascular and metabolic diseases |
63 |
16 |
25,4 % |
5 |
7,9 % |
Neuroscience |
163 |
16 |
9,8 % |
8 |
4,9 % |
Infectious diseases |
72 |
16 |
22,2 % |
8 |
11,1 % |
Oncology |
111 |
16 |
14,4 % |
6 |
5,4 % |
Enabling technologies |
137 |
16 |
11,7 % |
6 |
4,4 % |
546 |
80 |
14,7 % |
33 |
6,0 % |
|
Table 2: % of the preselected and selected projects compared to the submitted projects in each thematic area.
Thematic area |
Proj. Evaluated |
Proj. Preselected |
Proj. Selected |
|
|---|---|---|---|---|
Cardiovascular and metabolic diseases |
Individual |
22 |
5 |
1 |
Research Consortium |
41 |
11 |
4 |
|
Total |
63 |
16 |
5 |
|
Neuroscience |
Individual |
70 |
5 |
4 |
Research Consortium |
93 |
11 |
4 |
|
Total |
163 |
16 |
8 |
|
Infectious disease |
Individual |
33 |
7 |
7 |
Research Consortium |
39 |
9 |
1 |
|
Total |
72 |
16 |
8 |
|
Oncology |
Individual |
52 |
5 |
3 |
Research Consortium |
59 |
11 |
3 |
|
Total |
111 |
16 |
6 |
|
Enabling technologies |
Individual |
34 |
1 |
1 |
Research Consortium |
103 |
15 |
5 |
|
Total |
137 |
16 |
6 |
|
|
|
549 |
80 |
33 |
Table 3: Number of Individual and Research Consortium projects compared to the total number of projects of each thematic area.
Resultados Health Research 2021
Resultados Health Research 2021
Health Research 2021 Call for Proposals - information |
|
|---|---|
HR21 Budget |
22.115.490,50 € |
Number of projects presented |
644 |
Number of projects evaluated |
644 |
Number of projects preselected |
70 |
Number of projects selected |
30 |
Success rate |
4,66 % |
Table: General information of Health Research 2021 Call for Proposals.
Resultados Health Research 2020
Resultados Health Research 2020
Health Research 2020 Call for Proposals - information |
|
|---|---|
HR20 Budget |
15.200.128 € |
Number of projects presented |
602 |
Number of projects evaluated |
600 |
Number of projects preselected |
62 |
Number of projects selected |
21 |
Success rate |
3,50 % |
Table: General information of Health Research 2020 Call for Proposals.
Resultados Health Research 2019
Resultados Health Research 2019
Health Research 2019 Call for Proposals - information |
|
|---|---|
HR18 Budget |
15.376.337 € |
Number of projects presented |
632 |
Number of projects evaluated |
629 |
Number of projects preselected |
75 |
Number of projects selected |
22 |
Success rate |
3,50 % |
Table: General information of Health Research 2019 Call for Proposals.
Resultados Health Research 2018
Resultados Health Research 2018
Health Research 2018 Call for Proposals - information |
|
|---|---|
HR17 Budget |
12.000.000 € |
Number of projects presented |
785 |
Number of projects evaluated |
785 |
Number of projects preselected |
77 |
Number of projects selected |
20 |
Table: General information of Health Research 2018 Call for Proposals.
Projetos selecionados Health Research 2022
Projetos selecionados Health Research 2022
Code |
Project Title |
Project Leader |
Host Organization |
Partner Organizations |
Thematic Area |
Category |
Budget (€) |
|---|---|---|---|---|---|---|---|
HR22-00073 |
Andrés Aguilera |
Universidad de Sevilla |
N/A |
Oncology |
Individual |
500,000 |
|
HR22-00100 |
João Morais Cabral |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação |
N/A |
Infectious disease |
Individual |
498,999 |
|
HR22-00123 |
Jordi Figuerola |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Infectious disease |
Individual |
499,909.28 |
|
HR22-00172 |
Elías Campo |
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
Fundación Universidad de Oviedo; Centre de Regulació Genòmica (CRG) |
Oncology |
Research Consortium |
999,806.30 |
|
HR22-00189 |
Paulo Aguiar |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação |
Universidade do Porto; Consejo Superior de Investigaciones Científicas (CSIC); Centro Hospitalar Universitário do Porto, E.P.E. |
Enabling Technologies |
Research Consortium |
965,888.78 |
|
HR22-00221 |
Josep Dalmau |
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
Fundació Privada per a la Recerca i la Docència Sant Joan de Déu |
Neuroscience |
Research Consortium |
972,352.39 |
|
HR22-00253 |
Almudena R. Ramiro |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC |
Fundación Instituto de Investigación Sanitaria of the Fundación Jiménez Díaz |
Cardiovascular and associated metabolic diseases |
Research Consortium |
750,042.40 |
|
HR22-00316 |
Understanding and promoting the growth and regenerative functions of blood vessels in heart disease |
Rui Benedito |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC |
Centre de Regulació Genòmica (CRG); Fundació Institut de Recerca Contra la Leucèmia Josep Carreras; University Hospital RWTH Aachen |
Cardiovascular and associated metabolic diseases |
Research Consortium |
999,948.04 |
HR22-00394 |
Angel Barco |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Neuroscience |
Individual |
498,000 |
|
HR22-00395 |
Vascularized lymphoma on-chip: a multifaceted tool for translational research |
Patricia Perez |
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
European Molecular Biology Laboratory Barcelona |
Enabling Technologies |
Research Consortium |
499,871.26 |
HR22-00402 |
Fran Supek |
Fundació Institut de Recerca Biomèdica (IRB Barcelona) |
Universitat Pompeu Fabra (UPF) |
Oncology |
Research Consortium |
998,900.50 |
|
HR22-00405 |
Accelerated evolution of high-weight protein complexes for precision antimicrobials |
Alfonso Jaramillo |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Enabling Technologies |
Individual |
482,730 |
HR22-00447 |
Metabolic communication between immune cells orchestrates the response to pathogens |
Nuria Martínez |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Infectious disease |
Individual |
496,685.86 |
HR22-00529 |
Novel mutational mechanisms of somatic retrotransposition in the context of the 3D cancer genome |
Jose Tubio |
Universidad de Santiago de Compostela |
N/A |
Oncology |
Individual |
495,476.89 |
HR22-00533 |
A DIRect QuanTitative assessment of Heart disease with magnetic resonance imaging |
Teresa Matias |
Centro De Ciências Do Mar Do Algarve |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC; Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento; Universidad de Valladolid |
Cardiovascular and associated metabolic diseases |
Research Consortium |
998,472.90 |
HR22-00551 |
Claudio Franco |
Instituto de Medicina Molecular |
N/A |
Cardiovascular and associated metabolic diseases |
Individual |
499,818.88 |
|
HR22-00569 |
NRF2 as a novel therapeutic target in early and intermediate age-related macular degeneration |
Miguel Seabra |
Universidade Nova de Lisboa |
Centro Investigation Biomedica en Redes Neurodegenerativas - CIBERNED |
Neuroscience |
Research Consortium |
985,013 |
HR22-00602 |
Marta Martínez |
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) |
Universitat Autònoma de Barcelona (UAB); Centro de Investigación Príncipe Felipe |
Neuroscience |
Research Consortium |
599,723.00 |
|
HR22-00668 |
Uncovering the Differentiation Determinants and Dynamics of Congenital Susceptibility to Infections |
Esteban Ballestar |
Fundació Institut de Recerca Contra la Leucèmia Josep Carreras |
Fundació Josep Carreras contra la Leucemia |
Infectious disease |
Individual |
477,722.19 |
HR22-00681 |
Christian Brander |
Institut de Recerca de la Sida "la Caixa" - IRSICAIXA |
Centre de Regulació Genòmica (CRG); Fundació FLS de lluita contra la sida, les malalties infeccioses i la promoció de la salut i la ciencia; Institut De Recerca I Tecnología Agroalimentaria |
Infectious disease |
Research Consortium |
999,580 |
|
HR22-00702 |
Multifunctional nano-immunotherapy against breast brain metastases |
Helena Florindo |
FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento |
Tel Aviv University |
Enabling Technologies |
Research Consortium |
853,405.70 |
HR22-00722 |
The BioPlaTTAR Platform for the Tailored and Rapid Development of Antiviral Biopharmaceuticals |
Cláudio Manuel Soares |
Universidade Nova de Lisboa |
Instituto de Medicina Molecular; Fundação Calouste Gulbenkian; Consejo Superior de Investigaciones Científicas (CSIC) |
Enabling Technologies |
Research Consortium |
1,000,000 |
HR22-00732 |
Somatic mutations and clonal hematopoiesis as predictors and drivers of heart failure progression |
José Javier Fuster |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC |
Fundació Institut de Recerca Contra la Leucèmia Josep Carreras; Fundació Institut d’Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP); Fundació Josep Carreras contra la Leucemia; Fundació Institut de Recerca Biomèdica (IRB Barcelona); Fundación para la Formación e Investigación Sanitarias de la Región de Murcia |
Cardiovascular and associated metabolic diseases |
Research Consortium |
998,043.28 |
HR22-00741 |
Luis Graca |
Instituto de Medicina Molecular |
Cultivamos Cultura |
Infectious disease |
Individual |
499,952 |
|
HR22-00754 |
Manuela Ferreira |
Universidade de Coimbra |
N/A |
Infectious disease |
Individual |
408,077.71 |
|
HR22-00776 |
Role of cellular senescence during breast cancer progression and treatment |
Joaquín Arribas |
Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) |
N/A |
Oncology |
Individual |
500,000 |
HR22-00778 |
Leopoldo Petreanu |
Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud |
N/A |
Neuroscience |
Individual |
499,976.40 |
|
HR22-00799 |
Vera Sofia Correia Martins |
Fundação Calouste Gulbenkian |
Universität Ulm |
Oncology |
Research Consortium |
681,932.54 |
|
HR22-00813 |
Miguel A. Bañares |
Consejo Superior de Investigaciones Científicas (CSIC) |
Fundación para la Investigación Biomédica del Hospital Universitario La Paz; Hospital Universitario Severo Ochoa |
Enabling Technologies |
Research Consortium |
997,000 |
|
HR22-00854 |
Ira Milosevic |
Universidade de Coimbra |
N/A |
Neuroscience |
Individual |
492,837.85 |
|
HR22-00879 |
Cristina Cunha |
Universidade do Minho |
N/A |
Infectious disease |
Individual |
499,646.79 |
|
HR22-00890 |
Modulating nucleolar activity and stress responses as a therapeutic strategy in ALS |
Oscar Fernandez-Capetillo |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III |
N/A |
Neuroscience |
Individual |
498,850 |
Projetos selecionados Health Research 2021
Projetos selecionados Health Research 2021
Code |
Project Title |
Project Leader |
Host Organization |
Partner Organizations |
Thematic Area |
Category |
Budget (€) |
|---|---|---|---|---|---|---|---|
HR21-00046 |
Decoding the paracrine control of metabolic fitness by endothelial nutrient signaling |
Alejo Efeyan |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
Cardiovascular and associated metabolic diseases |
Research Consortium |
992.580,60 |
HR21-00386 |
Amadeu Llebaria |
Consejo Superior de Investigaciones Científicas (CSIC) |
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) - Purdue University, West Lafayette, IN - GICOR |
Cardiovascular and associated metabolic diseases |
Research Consortium |
999.779,50 |
|
HR21-00430 |
Antonio Zorzano |
Fundació Institut de Recerca Biomèdica (IRB Barcelona) |
Universitat de Barcelona - Fundació Institut d'Investigació Sanitària Pere Virgili |
Cardiovascular and associated metabolic diseases |
Research Consortium |
997.014 |
|
HR21-00233 |
Silvia Giuliana Priori |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC |
N/A |
Cardiovascular and associated metabolic diseases |
Individual |
496.100 |
|
HR21-00793 |
Cecilia Rodrigues |
FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento |
N/A |
Cardiovascular and associated metabolic diseases |
Individual |
320.000,07 |
|
HR21-00375 |
Ben Lehner |
Centre de Regulació Genòmica (CRG) |
Institut de Bioenginyeria de Catalunya |
Enabling technologies |
Research Consortium |
994.048,90 |
|
HR21-00925 |
Development of enabling technologies for T-cell immunotherapy of solid tumors |
Sonia Guedán |
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
Asociación Centro de Investigación Cooperativa en Biociencias (CIC bioGUNE) - Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO) |
Enabling technologies |
Research Consortium |
963.488 |
HR21-00410 |
Pedro Alpuim |
Laboratorio Iberico Internacional de Nanotecnologia |
Universidade do Minho - Consejo Superior de Investigaciones Científicas (CSIC) |
Enabling technologies |
Research Consortium |
997.692,19 |
|
HR21-00208 |
Enzyme propelled nanobots as efficient nanotech platform for bladder cancer therapy |
Samuel Sánchez |
Institut de Bioenginyeria de Catalunya |
Asociación Centro de Investigación Cooperativa en Biomateriales - Universitat Autònoma de Barcelona (UAB) - Fundació Clínic per a la Recerca Biomèdica -Fundacio Catalunya-La Pedrera Fundacio Especial - Universitat de Barcelona - Fundació Bosch i Gimpera |
Enabling Technologies |
Research Consortium |
997.946,50 |
HR21-00415 |
Margarida Saraiva |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação |
Consejo Superior de Investigaciones Científicas (CSIC) - Francis Crick Institute |
Infectious diseases |
Research Consortium |
998.404 |
|
HR21-00848 |
Whole-organism vaccines against P. falciparum and P. vivax malaria with enhanced efficacy and scope |
Miguel Prudêncio |
Instituto de Medicina Molecular |
Leiden University Medical Centre - US Naval Medical Research Unit 6 |
Infectious diseases |
Research Consortium |
997.453,50 |
HR21-01020 |
João Filipe Oliveira |
Universidade do Minho |
N/A |
Neuroscience |
Individual |
499.478,45 |
|
HR21-00171 |
Hernando A. del Portillo |
Institut de Salut Global de Barcelona (ISGlobal) |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação - Universitat de Barcelona - Mahidol University |
Infectious diseases |
Research Consortium |
996.930,57 |
|
HR21-00368 |
Molecular dissection of TNF-mediated pathogenic macrophage necrosis in tuberculosis |
Francisco Jose Roca Soler |
Universidad de Murcia |
N/A |
Infectious diseases |
Individual |
460.252,80 |
HR21-00737 |
Toni Gabaldón |
Fundació Institut de Recerca Biomèdica (IRB Barcelona) |
N/A |
Infectious diseases |
Individual |
499.244 |
|
HR21-00622 |
In vivo reprogramming to rescue alterations in Huntington’s disease |
Josep M. Canals |
Universitat de Barcelona - Fundació Bosch i Gimpera |
Lund University - Cardiff University - Institute of Molecular Biotechnology (IMBA)- European Huntington's Disease Network |
Neuroscience |
Research Consortium |
994.890 |
HR21-00259 |
From GFAP mutations in astrocytes to neurodegeneration: exploring a lipid-protein oxidation pathway |
Dolores Pérez-Sala |
Consejo Superior de Investigaciones Científicas (CSIC) |
Brain Center, University Medical Center Utrecht -University of Copenhagen - University of Gothenburg -Institut De Recerca Biomedica De Lleida. Fundació Dr. Pifarre |
Neuroscience |
Research Consortium |
1.000.000 |
HR21-00824 |
A strategy to guide and promote spinal and visual axons regeneration after injury |
Eloísa Herrera |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Neuroscience |
Individual |
495.500 |
HR21-01136 |
Deep learning of a hippocampal memory code in health and disease |
Liset Menéndez de la Prida |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Neuroscience |
Individual |
491.700 |
HR21-01208 |
RBM10, a novel splicing regulator and tumor suppressor: from mechanisms to therapies |
Juan Valcárcel |
Centre de Regulació Genòmica (CRG) |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III |
Oncology |
Research Consortium |
816.239,46 |
HR21-00176 |
Maite Huarte |
Fundación para la Investigación Médica Aplicada (FIMA/CIMA) |
Consejo Superior de Investigaciones Científicas (CSIC) - Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III |
Oncology |
Research Consortium |
995.200 |
|
HR21-00761 |
IL7R in lung cancer development, metastasis and resistance to immune checkpoint inhibitor therapy |
João Barata |
Instituto de Medicina Molecular |
Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre - Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III |
Oncology |
HR Consortium |
999.962 |
HR21-00083 |
Interleukin-8 and neutrophil extracelular traps as actionable hurdles for cancer immunotherapy |
Ignacio Melero |
Fundación para la Investigación Médica Aplicada (FIMA/CIMA) |
N/A |
Oncology |
Individual |
498.850 |
HR21-00020 |
Helder Maiato |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação |
N/A |
Oncology |
Individual |
499.983 |
|
| Projetos premiados em colaboração com a Fundação Luzon | |||||||
HR21-00931 |
Targeting TDP-43 with protein kinase inhibitors: a effective and measurable therapy for ALS |
Ana Martinez |
Consejo Superior de Investigaciones Científicas (CSIC) |
FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento -Universidad Complutense de Madrid |
Neuroscience |
Research Consortium |
500.000 |
| Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b" | |||||||
HR21-01212 |
Jose Bessa |
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação |
N/A |
Cardiovascular and associated metabolic diseases |
Individual |
499.355 |
|
HR21-00605 |
Miguel Castanho |
Instituto de Medicina Molecular |
Asociación Instituto Biodonostia - FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento - Asociación Centro de Investigación Cooperativa en Biomateriales |
Enabling Technologies |
Research Consortium |
632.841 |
|
HR21-00533 |
A flexible platform for generating synthetic virus to control infectious diseases |
Joana Azeredo |
Universidade do Minho |
N/A |
Infectious diseases |
Individual |
492.460,48 |
HR21-01077 |
Paulo Pinheiro |
Centro de Neurociências e Biologia Celular |
N/A |
Neuroscience |
Individual |
492.304,48 |
|
HR21-00077 |
Claus Maria Azzalin |
Instituto de Medicina Molecular |
N/A |
Oncology |
Individual |
495.792 |
|
Projetos selecionados Health Research 2020
Projetos selecionados Health Research 2020
Code |
Project Title |
Project Leader |
Host Institution |
Partner Institutions |
Thematic Area |
Category |
Budget (€) |
|---|---|---|---|---|---|---|---|
HR20-00493 |
Manuel Irimia |
Centre de Regulació Genòmica (CRG) |
N/A |
Cardiovascular and metabolic diseases |
Individual |
499.592 |
|
HR20-00075 |
Miguel Ángel del Pozo |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC |
Yale University, New Haven, CT, Aarhus University, Asociación Centro de Investigación Cooperativa en Biomateriales |
Cardiovascular and metabolic diseases |
Research Consortium |
999.987 |
|
HR20-00322 |
RNA mis-splicing in hypertrophic cardiomyopathy: opportunities for diagnosis and therapy |
Maria Carmo-Fonseca |
Instituto de Medicina Molecular |
Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento, Associação para Investigação e Desenvolvimento da Faculdade de Medicina |
Cardiovascular and metabolic diseases |
Research Consortium |
986.964 |
HR20-00051 |
Succinate/SUCNR1 axis: a novel target for anti-obesity therapies |
Sonia Fernandez |
Fundació Institut d'Investigació Sanitària Pere Virgili |
Universidad de Santiago de Compostela, Institut D'Investigació Biomèdica De Girona (IDIBGI) |
Cardiovascular and metabolic diseases |
Research Consortium |
998.902 |
HR20-00369 |
Enabling technologies to map nuclear mechanosensing: from organoids to tumors |
Xavier Trepat |
Institut de Bioenginyeria de Catalunya |
Netherlands Cancer Institute |
Enabling technologies |
Research Consortium |
984.630 |
HR20-00800 |
Deep Learning to Dissect the Interaction between Leukemic Cells and the Ageing Niche |
M. Carolina Florian |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Universität Ulm |
Enabling technologies |
Research Consortium |
817.045 |
HR20-00637 |
BioPrinted hydROgel MicrofluIdicS to mimic patient-specific tumor mEtastatic microenvironment |
Elena Martinez |
Institut de Bioenginyeria de Catalunya |
Laboratorio Ibérico Internacional de Nanotecnologia, Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO) |
Enabling technologies |
Research Consortium |
981.675 |
HR20-00428 |
Gemma Triola |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Enabling technologies |
Individual |
341.242 |
|
HR20-00218 |
Enhancing Tissue-Specific Immune Microenvironments for the Cure of HIV |
María José Buzón |
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) |
Consejo Superior de Investigaciones Científicas (CSIC), Institut de Recerca de la Sida "la Caixa" - IRSICAIXA |
Infectious diseases |
Research Consortium |
699.134 |
HR20-00361 |
Mechanism and function of epitranscriptomic poly(A) tail modifications in African trypanosomes |
Luisa Figueiredo |
Instituto de Medicina Molecular Joao Lobo Antunes |
N/A |
Infectious diseases |
Individual |
499.400 |
HR20-00635 |
Elena Gomez-Díaz |
Consejo Superior de Investigaciones Científicas (CSIC) |
University of Glasgow, University of Sciences, Techniques and Technologies of Bamako (USTTB), Malaria Rsearch and Training Center |
Infectious diseases |
Research Consortium |
999.548 |
|
HR20-00584 |
Olga Genilloud |
Fund. Centro de Excelencia en Inv. de Medicamentos Innovadores en Andalucia |
Drugs for Neglected Diseases Initiative (DNDi), Institut Pasteur korea |
Infectious diseases |
Research Consortium |
995.251 |
|
HR20-01000 |
Encoding reward and aversion in the mammalian brain: the overlooked role of endogenous opioids |
Ana Joao Rodrigues |
Universidade do Minho |
N/A |
Neuroscience |
Individual |
499.788 |
HR20-00083 |
Restoration of sensory circuits based on glia-to-neuron reprogramming |
Guillermina López-Bendito |
Consejo Superior de Investigaciones Científicas (CSIC) |
N/A |
Neuroscience |
Individual |
499.000 |
HR20-00081 |
Amino acid transporter structure to target glutamate transmission in neuro diseases |
Manuel Palacin |
Fundació Institut de Recerca Biomèdica (IRB Barcelona) |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III |
Neuroscience |
Research Consortium |
428.500 |
HR20-00896 |
Mitochondrial transcription as a trigger for neurodegenation |
Albert Quintana |
Universitat Autònoma de Barcelona (UAB) |
N/A |
Neuroscience |
Individual |
500.000 |
HR20-00714 |
Guglielmo Foffani |
Fundación de Investigación HM Hospitales |
N/A |
Neuroscience |
Individual |
500.000 |
|
HR20-00465 |
Immunomodulatory drivers in melanoma progression and therapy response |
Marisol Soengas |
Fund. del Sector Público Estatal Centro Nacional de Inv. Oncológicas Carlos III |
N/A |
Oncology |
Individual |
481.597 |
HR20-00164 |
Xose R. Bustelo |
Fundación de Investigación del Cancer |
N/A |
Oncology |
Individual |
498.300 |
|
HR20-00871 |
Felipe Prosper |
Universidad de Navarra |
Fundación para la Investigación Médica Aplicada (FIMA/CIMA), Fundación Miguel Servet - Navarrabiomed, University of Cambridge |
Oncology |
Research Consortium |
999.410 |
|
HR20-00411 |
Luciano Di Croce |
Centre de Regulació Genòmica (CRG) |
Fundació Sant Joan de Déu |
Oncology |
Research Consortium |
990.160 |
|
| Proyectos galardonados en colaboración con la Fundación Luzón | |||||||
HR20-01109 |
Brain Liquid Biopsy for Alzheimer disease and neurodegenerative disorders |
Maite Mendioroz |
Fundación Miguel Servet - Navarrabiomed |
N/A |
Neuroscience |
Individual |
482.847 |
| Proyectos galardonados en colaboración con la Fundação para a Ciência e a Tecnologia, I.P. en el marco de la “Iniciativa Ibérica de Investigaçao e Inovaçao Biomédica, i4b" | |||||||
HR20-00249 |
Jana B. Nieder |
Laboratorio Ibérico Internacional de Nanotecnologia |
Universidade do Minho, Universidade de Aveiro |
Enabling technologies |
Research Consortium |
999.981 |
|
HR20-00841 |
Henrique Veiga-Fernandes |
Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud |
N/A |
Infectious disease |
Individual |
499.950 |
|
HR20-00904 |
Potassium channel dysfunction in models of neurodevelopmental disorders |
Ana Luisa Carvalho |
Centro de Neurociências e Biologia Celular |
IINS - Interdisciplinary Institute for Neuroscience, CNRS 5297, University of Bordeaux |
Neuroscience |
Research Consortium |
782.000 |
Projetos selecionados Health Research 2019
Projetos selecionados Health Research 2019
Code |
Project Title |
Project Leader |
Host Institution |
Partner Institutions |
Thematic Area |
Category |
Budget (€) |
|---|---|---|---|---|---|---|---|
HR1818-00120 |
Mariona Graupera |
Institut d'Investigació Biomèdica de Bellvitge |
Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.), Fundación Privada Hospital de la Santa Creu i Sant Pau, Fundació Sant Joan de Déu |
Cardiovascular and metabolic diseases |
Research Consortium |
755.018 |
|
HR1818-00068 |
Juan Miguel Redondo Moya |
Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) |
Consejo Superior de Investigaciones Científicas |
Cardiovascular and metabolic diseases |
Research Consortium |
500.000 |
|
HR1818-00304 |
Dysfunction of Ion Channel Complexes in Inheritable Cardiac Diseases |
José Jalife |
Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) |
N/A |
Cardiovascular and metabolic diseases |
Individual |
499.895 |
HR1818-00100 |
Marc Claret Carles |
Institut d'Investigacions Biomèdiques August Pi i Sunyer |
Université catholique de Louvain (UCLouvain), Universidad de Santiago de Compostela |
Cardiovascular and metabolic diseases |
Research Consortium |
972.183 |
|
HR1818-00359 |
Origin and functions of the tumor stroma in metastatic colorectal cancer |
Eduard Batlle |
Fundació Institut de Recerca Biomèdica (IRB Barcelona) |
N/A |
Oncology |
Individual |
499.997 |
HR1818-00069 |
Next-generation CAR-DOT cells for allogeneic adoptive cancer immunotherapy |
Bruno Miguel de Carvalho Silva-Santos |
Instituto de Medicina Molecular |
Josep Carreras Leukemia Research Institute (JCLRI) |
Oncology |
Research Consortium |
999.997 |
HR1818-00302 |
Post-transcriptional gene regulation reprogramming in obesity-driven liver cancer |
Raúl Méndez |
Fundació Institut de Recerca Biomèdica (IRB Barcelona) |
N/A |
Oncology |
Individual |
499.883 |
HR1818-00256 |
Defining The Role of Exosome-Secreted Micropeptides in Pancreatic Cancer |
Maria Abad |
Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO) |
Fundación Centro Nacional de Investigaciones Oncológicas Carlos III, Champalimaud Foundation |
Oncology |
Research Consortium |
694.600 |
HR1818-00023 |
Maria A. Blasco |
Fundación Centro Nacional de Investigaciones Oncológicas Carlos III |
N/A |
Oncology |
Individual |
489.100 |
|
HR1818-00589 |
Sensitizing pancreatic cancer to immunotherapy with multimodal precision nanomedicines |
Maria Jesús Vicent Docón |
Centro de Investigación Príncipe Felipe |
Facultade de Farmacia da Universidade de Lisboa, Sackler Faculty of Medicine. Tel Aviv University |
Enabling technologies |
Research Consortium |
985.042 |
HR1818-00501 |
Pau Gorostiza Langa |
Institut de Bioenginyeria de Catalunya |
Universidad Miguel Hernández de Elche (UMH), Consejo Superior de Investigaciones Científicas, Barcelona Macula Foundation Research (BMF), Universidad de Alcalá (UAH) |
Enabling technologies |
Research Consortium |
498.051 |
|
HR1818-00336 |
Community-Driven Big Data Intelligence to Fight Mosquito-Borne Disease |
Frederic Bartumeus Ferré |
Consejo Superior de Investigaciones Científicas |
Universitat Pompeu Fabra, Max Planck Institute for Demographic Research (MPDIR), National Center of Epidemiology (CNE). CIBERESP/ISCIII., Centre for Ecological Research and Forestry Applications (CREAF), Agència de Salut Pública de Barcelona (ASPB),Agencia de Salut Pública de Catalunya (ASPCAT). Generalitat de Catalunya, Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES) |
Enabling technologies |
Research Consortium |
999.920 |
HR1818-00313 |
Jose Antonio Garrido Ariza |
Fundació Institut Català de Nanociència i Nanotecnologia |
Institut de Física d'Altes Energies (IFAE), The Institute of Photonic Sciences (ICFO), Barraquer Foundation (BF), Institut de la Vision (Sorbonne Université) |
Enabling technologies |
Research Consortium |
999.715 |
|
HR1818-00058 |
Bacterial lung chassis for treating human lung infectious diseases |
Luis Serrano Pubul |
Fundació Centre de Regulació Genòmica |
Institut d'Investigacions Biomèdiques August Pi i Sunyer |
Infectious diseases |
Research Consortium |
999.528 |
HR1818-00469 |
Carmen Gil |
Consejo Superior de Investigaciones Científicas |
Instituto de Investigación Biomédica Hospital 12 de Octubre (Imas12), Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Bernhard Nocht Institute for Tropical Medicine |
Infectious disease |
Research Consortium |
995.068 |
|
HR1818-00267 |
Alfred Cortés Closas |
Barcelona Institute for Global Health (ISGlobal) |
N/A |
Infectious diseases |
Individual |
499.400 |
|
HR1818-00104 |
Marc Veldhoen |
Instituto de Medicina Molecular |
N/A |
Infectious diseases |
Individual |
497.158 |
|
HR1818-00155 |
Exosome targeting of the hypothalamus: a novel strategy for the treatment of obesity |
Miguel Antonio López Pérez |
Universidad de Santiago de Compostela |
N/A |
Neuroscience |
Individual |
448.300 |
HR1818-00026 |
DUbbing Language-therapy CINEma-based in Aphasia post-Stroke. A feasibility cross-over pilot-trial |
Blanca Fuentes Gimeno |
Hospital Universitario la Paz |
Universidad Pontificia de Comillas, Afasia Activa |
Neuroscience |
Research Consortium |
308.066 |
HR1818-00178 |
Manuel Francisco Carreiras Valiña |
Asociacion Basque Center on Cognition, Brain and Language |
N/A |
Neuroscience |
Individual |
500.000 |
|
HR1818-00452 |
José Antonio Del Río Fernández |
Institut de Bioenginyeria de Catalunya |
Institut d'Investigació Biomèdica de Bellvitge, Institute for Research in Biomedicine (IRB Barcelona), Universitat de Barcelona and Institute of Complex Systems (UBICS) |
Neuroscience |
Research Consortium |
763.002 |
|
HR1818-00007 |
Oscar Vilarroya Oliver |
Universitat Autònoma de Barcelona |
Fundació Institut Mar d'Investigacions Mèdiques, Instituto de Investigación Sanitaria Gregorio Marañón , University of Lleida-IRBLleida, Reproductive Medicine Service at Dexeus Women Health |
Neuroscience |
Research Consortium |
972.414 |
|
| Projetos premiados em colaboração com a Fundação Luzon | |||||||
HR1818-000341 |
A potential metabolic-targeted therapeutic for Amyotrophic lateral sclerosis (ALS): Leptin |
Carmen Maria Fernandez-Martos |
Fundación Hospital Nacional de Parapléjicos |
San Pablo University, King´s College London and Wicking Dementia Centre/University of Tasmania |
Neuroscience |
Research Consortium |
499979 |
| Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b" | |||||||
HR1818-00187 |
Targeting induced-senescent cells: a novel approach to promote spinal cord regeneration in mammals |
Leonor Saúde |
Instituto de Medicina Molecular |
N/A |
Neuroscience |
Individual |
444048 |
HR1818-00502 |
Miguel Che Parreira Soares |
Fundação Calouste Gulbenkian |
Universitätsklinikum Jena, Center for Sepsis Control and Care, Thüringen (Germany) |
Infectious disease |
Research Consortium |
500000 |
|
Projetos selecionados Health Research 2018
Projetos selecionados Health Research 2018
Code |
Project Title |
Project Leader |
Host Institution |
Partner Institutions |
Thematic Area |
Category |
Budget (€) |
|---|---|---|---|---|---|---|---|
HR17- 00016 |
Francisco Sánchez-Madrid |
Centro Nacional de Investigaciones Cardiovasculares (CNIC) |
N/A |
Infectious disease |
A |
499.731 |
|
HR17- 00040 |
Pura Muñoz-Cánoves |
Universitat Pompeu Fabra (UPF) |
N/A |
Other biomedical areas |
A |
496.630 |
|
HR17- 00092 |
Roger Gomis Cabré |
Institute for Research in Biomedicine (IRB) |
N/A |
Oncology |
A |
489.400 |
|
HR17- 00094 |
Eradicating prostate cancer metastasis before clinical manifestation |
Arkaitz Carracedo |
CIC bioGUNE |
University of Cambridge (UK), Fundação Champalimaud (Lisboa), CIC biomaGUNE, Basurto Hospital |
Oncology |
A |
499.915 |
HR17- 00149 |
Josep Dalmau Obrador |
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
N/A |
Neuroscience |
A |
498.718 |
|
HR17- 00199 |
Towards a universal therapeutic vaccine against chronic virus infections |
Andreas Meyerhans |
Universitat Pompeu Fabra (UPF) |
IrsiCaixa |
Infectious disease |
A |
484.316 |
HR17- 00221 |
Elías Campo |
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
Universidad de Oviedo (UNIOVI), Barcelona Supercomputing Center (BSC) |
Oncology |
B |
999.270 |
|
HR17- 00231 |
Maria Pia Cosma |
Fundació Centre de Regulació Genòmica (CRG) |
Institute for Bioengineering of Catalonia (IBEC), Instituto Barraquer |
Neuroscience |
A |
499.519 |
|
HR17- 00232 |
Exploiting post-transcriptional regulation to uncover novel vulnerabilities of metastatic cells |
Fátima Gebauer Hernández |
Fundació Centre de Regulació Genòmica (CRG) |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Oncology |
A |
499.980 |
HR17- 00247 |
Almudena Rodríguez Ramiro |
Centro Nacional de Investigaciones Cardiovasculares (CNIC) |
Fundación Jimenez Diaz |
Cardiovascular disease |
A |
499.963 |
|
HR17- 00264 |
Plasmodium Exploitation of Liver-specific Methionine Metabolism |
Maria M. Mota |
Instituto de Medicina Molecular (IMM), Lisboa |
N/A |
Infectious disease |
A |
499.950 |
HR17- 00267 |
Somatic Mutation-driven Clonal Hematopoiesis in Atherosclerosis - International Consortium |
Valentí Fuster |
Centro Nacional de Investigaciones Cardiovasculares (CNIC) |
University of Virginia (UVA) |
Cardiovascular disease |
B |
999.896 |
HR17- 00268 |
Therapeutic targeting of MBNL microRNAs as innovative treatments for myotonic dystrophy |
Ruben Artero-Allepuz |
Universitat de Valencia |
University of Oxford (UK), Institute for Bioengineering of Catalonia (IBEC), Institut IMAGINE (France), Institute Biodonostia, ASEM & Myotonic Dystrophy Foundation |
Other biomedical areas |
B |
997.024 |
HR17- 00323 |
Optical dissection of cortical circuits for sensory expectations |
Leopoldo Petreanu |
Fundação Champalimaud, Lisboa |
N/A |
Neuroscience |
A |
499.708 |
HR17- 00409 |
David Andreu Martínez |
Universitat Pompeu Fabra (UPF) |
Instituto de Medicina Molecular (IMM), Instituto de Bioquímica Médica Leopoldo de Meis |
Infectious disease |
B |
777.250 |
|
HR17- 00513 |
Miquel Vila Bover |
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) |
N/A |
Neuroscience |
A |
466.004 |
|
HR17- 00527 |
Therapeutic targeting of the neutrophil clock in cardiovascular disease |
Andrés Hidalgo Alonso |
Centro Nacional de Investigaciones Cardiovasculares (CNIC) |
Universidad Complutense de Madrid (UCM), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) |
Cardiovascular disease |
A |
499.998 |
HR17- 00539 |
Carlos Vidal Ribeiro |
Fundação Champalimaud, Lisboa |
N/A |
Neuroscience |
A |
463.694 |
|
HR17- 00595 |
Colin Adrain |
Calouste Gulbenkian Foundation, Lisboa |
Institute of Chemical and Biological Technology (ITQB-NOVA, Lisboa), Institute of Organic Chemistry and Biochemistry of the CAS (Czech Republic) |
Other biomedical areas |
B |
960.769 |
|
HR17- 00627 |
Ofelia María Martínez Estrada |
Fundació Bosch i Gimpera (UB) |
Fundació Hospital Universitari Vall d'Hebron Institut de Recerca (VHIR), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP) |
Cardiovascular disease |
A |
438.100 |
|
| Projetos premiados em colaboração com a Fundação Luzon | |||||||
HR17- 00777 |
Rubèn López Vales |
Universitat Autònoma de Barcelona (UAB) |
N/A |
Neuroscience |
A |
500.000 |
|
| Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b" | |||||||
HR17- 00523 |
Rodrigo A. Cunha |
Centro de Neurociências e Biologia Celular (CNC), Coimbra |
N/A |
Neuroscience |
A |
333.516 |
|
HR17- 00634 |
Agostinho Albérico Rodrigues de Carvalho |
Universidade do Minho |
Fundación Universitaria San Pablo (CEU), Foundation for Research and Technology-Hellas, Jena University Hospital and Radboudumc |
Infectious disease |
B |
999.027 |
|
HR17- 00601 |
Exosomal fat-liver axis in nonalcoholic fatty liver disease: function and targeting |
Rui Eduardo Mota Castro |
Universidade de Lisboa |
Instituto Biodonostia, École polytechnique fédérale de Lausanne (EPFL) and CIC bioGUNE |
Other biomedical areas |
A |
500.000 |
HR17- 00636 |
Joaquim Adelino Correia Ferreira Leite Moreira |
Universidade do Porto |
N/A |
Cardiovascular disease |
A |
369.248 |
|